Carcinoma, Non-Small-Cell Lung: all 6,645 studies
Page 48 of 67. Open to participants first (1,667), then studies with results posted, then the rest; newest registration first within each.
- A Study of the Efficacy and Safety of Alectinib in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung CancerCompletedNCT03155009Phase 2
- Effect of Genetic Polymorphisms on Platinum Based Chemotherapy in Non Small Cell Lung CancerStatus unknownNCT03154242
- Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) MutationStatus unknownNCT03151161Phase 2
- Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body RadiotherapyTerminatedNCT03148327Phase 1/2
- Hypermetabolism in the Elderly Lung Cancer PatientCompletedNCT03141957
- Resistance & Activating Mutations Diagnosed Among NSCLC Community Dwelling EGFR Mutation Positive PatientsCompletedNCT03137264
- A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLCCompletedNCT03134872Phase 3
- Pembrolizumab for Metastatic NSCLC Patients Expressing PD-L1 Who Have Their Own PDXCompletedNCT03134456Phase 4
- Effect of Osimertinib in Ethnic Chinese With EGFR and T790M Mutated NSCLCCompletedNCT03133234
- Nivolumab in the Real World: Analysis of the Expanded Use in Spanish PatientCompletedNCT03132493
- Phase I Study of a Selective ALK Inhibitor PLB1003 in Patients With ALK+ NSCLC.Status unknownNCT03130881Phase 1
- To Evaluate the QoL Improvement of Oral Oligo Fucoidan in Subjects Receiving Platinum-based Chemotherapy With NSCLCWithdrawnNCT03130829Not applicable
- Durvalumab and Tremelimumab for Adjuvant Therapy of Resected NSCLCWithdrawnNCT03130764Phase 2
- A Study of the Correlation Between CRF, Survival and Physiological Factors in NSCLC Patients Under ChemotherapyStatus unknownNCT03130192
- An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung CancerCompletedNCT03129256Phase 2
- AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR MutationsTerminatedNCT03127449Not applicable
- A Study of Apatinib Plus Docetaxel for Treatment of Advanced Non-squamous Non-small Cell Lung Cancer With Bone MetastasesStatus unknownNCT03127319Phase 2
- A Study of Tarceva vs. Avastin+Tarceva for Advanced NSCLC With EGFR m(+)Status unknownNCT03126799Phase 2
- Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung CancerCompletedNCT03125603
- β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLCStatus unknownNCT03123484Phase 2
- Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung CancerActive, not recruitingNCT03122717Phase 1/2
- Nivolumab in Treating Patients With Advanced Metastatic Non-small Cell Lung CancerWithdrawnNCT03121417Phase 2
- Local Non-salvage Radiotherapy for Synchronous Oligometastatic Non-small-cell Lung Cancer.Status unknownNCT03119519Phase 2
- Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung CancerCompletedNCT03117335Phase 3
- Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung CancerActive, not recruitingNCT03110978Phase 2
- Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung CancerStatus unknownNCT03108560Not applicable
- Understanding Evidence-Based Practice Patterns in Advanced NSCLCCompletedNCT03107156Not applicable
- Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid TumoursCompletedNCT03101839Phase 1
- PET/CT-directed Hyperfractionated Radiation Dose Escalation in Stage III Non-small Cell Lung CancerCompletedNCT03099577Not applicable
- A Phase I Trial of LY3143921 Hydrate in Solid TumoursCompletedNCT03096054Phase 1
- Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung CancerCompletedNCT03092986Phase 4
- A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer SpecimensCompletedNCT03092739
- Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung CancerCompletedNCT03091816
- Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung CancerTerminatedNCT03091491Phase 2
- Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT03087448Phase 1
- Phase II Lung Metcore - Preoperative Metformin for Lung CancerCompletedNCT03086733Phase 2
- A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLCStatus unknownNCT03085069Phase 2
- A Phase III Trial of Recombinant Human Apo-2 Ligand for InjectionStatus unknownNCT03083743Phase 3
- BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung CancerCompletedNCT03083691Phase 2
- A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) MutationsTerminatedNCT03082300Phase 1
- Prognostic Value of PD-L1 in NSCLCStatus unknownNCT03078959
- Pilot Study of Regional Lung VentilationCompletedNCT03077113Not applicable
- A Study Evaluating MM-310 in Patients With Solid TumorsStatus unknownNCT03076372Phase 1
- Targeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLCStatus unknownNCT03074864Phase 2/3
- Plasma miRNAs Predict Radiosensitivity of Different Fractionation Regimes in Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer：Multicenter Controlled Study.(RadmiR-01)CompletedNCT03074175Not applicable
- Metformin Plus TKI Use in Patients With Non-Small Cell Lung CarcinomaStatus unknownNCT03071705Not applicable
- Microbiota and the Lung CancerActive, not recruitingNCT03068663Not applicable
- Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung CancerActive, not recruitingNCT03066297
- Pre Radiotherapy Daily Exercise Training in Non-Small Cell Lung CancerStatus unknownNCT03066271Not applicable
- Poziotinib in EGFR Exon 20 Mutant Advanced NSCLCTerminatedNCT03066206Phase 2
- 89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung CancerStatus unknownNCT03065764Phase 2
- PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC PatientsTerminatedNCT03064854Phase 1
- Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003)Status unknownNCT03062800Phase 2
- Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC)Status unknownNCT03060343Early Phase 1
- Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in ChinaCompletedNCT03059641
- A Study Comparing AC0010 and Chemotherapy in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKIWithdrawnNCT03058094Phase 3
- The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of TcellsStatus unknownNCT03057340Phase 1
- Prognostic Evaluation of Tumor Volume and Its Changes in Radical Radiotherapy of Advanced NSCLCCompletedNCT03055715
- Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung CancerTerminatedNCT03054038Phase 1
- Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer PatientsStatus unknownNCT03053856Phase 2
- Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis PredictionStatus unknownNCT03053804Not applicable
- Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)TerminatedNCT03053297
- Preliminary Evaluation of Safety and Efficacy by [14C] AC0010 Trail and Subsequent AC0010 TreatmentCompletedNCT03053219Phase 1
- A Study Comparing Pemetrexed Plus Cisplatin Versus Pemetrexed Alone in NSCLC Patients Who Have Progressed on First Line EGFR-TKIStatus unknownNCT03050437Phase 2
- Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung CancerStatus unknownNCT03050411Phase 1
- A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung CancerWithdrawnNCT03048136Phase 3
- Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLCCompletedNCT03044626Phase 2
- Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment AloneActive, not recruitingNCT03040973Phase 2
- Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung CancerTerminatedNCT03030131Phase 2
- Oncolytic Adenovirus-Mediated Gene Therapy for Lung CancerWithdrawnNCT03029871Phase 1
- NY-ESO-1 TCR （TAEST16001）for Patients With Advanced NSCLCStatus unknownNCT03029273Phase 1
- Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal DiseaseActive, not recruitingNCT03025256Phase 1
- Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation LoadsWithdrawnNCT03023904Phase 2
- Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid TumorsCompletedNCT03023319Phase 1
- Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLCStatus unknownNCT03008109Phase 3
- High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung CancerCompletedNCT03007875Phase 1/2
- Study of Split-course Chemoradiotherapy For Postoperative Locoregional Recurrence Of Non-small Cell Lung CancerStatus unknownNCT03006575Phase 2
- MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT03004105Phase 2
- EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion PolymorphismStatus unknownNCT03002844Phase 2
- Study to Investigate the Absorption, Metabolism and Excretion of [14C] AC0010 in Patients With Advanced NSCLCCompletedNCT03001609Phase 1
- Combination Study of Guadecitabine/ASTX727 and PembrolizumabActive, not recruitingNCT02998567Phase 1
- Complete Endosonographic Intrathoracic Nodal Staging of Lung Cancer Patients in Whom SABR is ConsideredStatus unknownNCT02997449
- Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU)Status unknownNCT02996214Phase 4
- FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung CancerCompletedNCT02995889Not applicable
- Atezolizumab as Induction Therapy in Non-small Cell Lung CancerCompletedNCT02994576Phase 2
- Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung CancerActive, not recruitingNCT02991924
- Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLCTerminatedNCT02991651Phase 1
- A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid TumorsActive, not recruitingNCT02988960Phase 1
- EGFR-TKI Resistance Profile in Chinese Patients With Advanced EGFRm+ NSCLCStatus unknownNCT02988141
- Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLCTerminatedNCT02987998Phase 1
- Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal CancerActive, not recruitingNCT02983578Phase 2
- cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia ChinaStatus unknownNCT02980536
- Combining Radiosurgery and Nivolumab in the Treatment of Brain MetastasesCompletedNCT02978404Phase 2
- 99mTc/68Ga Labeled Anti-PD-L1 sdAb in Assessment of PD-L1 Expression in NSCLCCompletedNCT02978196Early Phase 1
- Effect of Qigong on the Symptom Clusters of Dyspnea, Fatigue, and Anxiety.CompletedNCT02977845Not applicable
- To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung CancerStatus unknownNCT02977169Phase 2
- A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung CancerCompletedNCT02976116Phase 2
- Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung CancerStatus unknownNCT02975609Phase 2
- Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung CancerStatus unknownNCT02974933Phase 2
- A Phase Ib Study of LXH254-centric Combinations in NSCLC or MelanomaTerminatedNCT02974725Phase 1